Verastem Advances Copiktra for Peripheral T-cell Lymphoma Under LLS Therapy Acceleration Program
News
Aiming to accelerate the development of Copiktra (duvelisib) for treatment of peripheral T-cell lymphoma (PTCL) — an aggressive type of non-Hodgkin’s lymphoma — Verastem has announced a collaboration with the Leukemia & Lymphoma Society (LLS). ... Read more